Diversity of T cell receptor α and β chain genes expressed by human T cells specific for similar myelin basic protein peptide/major histocompatibility complexes

T cell receptor (TcR) α and β nucleotide sequences involved in the human autoreactivity to myelin basic protein (MBP) were studied by screening cDNA libraries derived from 11 independent T lymphocyte clones (TCC) established from multiple sclerosis patients and healthy donors. The TCC with defined MBP peptide specificity and HLA‐DR restriction expressed multiple TcR. Even TCC recognizing the same human MBP peptide [amino acids (aa) 139–153] in identical or very similar HLA‐DR context expressed diverse TcR. Two TCC which recognized peptide aa 139–153 equally well in the context of both HLA‐DR2a and ‐DR1 molecules used distinct TcR α but identical β chains.

[1]  G. Nedwin,et al.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Necker,et al.  Engineered secreted T-cell receptor alpha beta heterodimers. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  P. D. Smith,et al.  Genetic differences in the T cell receptor alleles of LEW rats and their encephalomyelitis‐resistant derivative, LER, and their impact on the inheritance of EAE resistance , 1991, European journal of immunology.

[4]  H. Weiner,et al.  T-cell recognition of myelin basic protein. , 1991, Immunology today.

[5]  R. Liblau,et al.  T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects , 1991, European journal of immunology.

[6]  S. Roman-Roman,et al.  Studies on the human T cell receptor α/β variable region genes. I. Identification of 7 additional Vα subfamilies and 14 Jα gene segments , 1991 .

[7]  S. Roman-Roman,et al.  Studies on the human T cell receptor α/β variable region genes. II. Identification of four additional Vβ subfamilies , 1991 .

[8]  A. Ben-nun,et al.  Restricted T-cell receptor V beta gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T. Olsson,et al.  Chronic experimental autoimmune encephalomyelitis induced by the 89‐101 myelin basic protein peptide in B10RIII (H2r) mice , 1991, European journal of immunology.

[10]  D. Bourdette,et al.  Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein , 1991, Journal of neuroscience research.

[11]  Eric O Long,et al.  A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis , 1991, The Journal of experimental medicine.

[12]  Eric O Long,et al.  HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. , 1990, Journal of immunology.

[13]  L. Kappos,et al.  Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals , 1990, Neurology.

[14]  L. Kappos,et al.  Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple-sclerosis patients and healthy donors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Raus,et al.  Preferential peptide specificity and HLA restriction of myelin basic protein-specific T cell clones derived from MS patients. , 1990, Cellular immunology.

[16]  Eric O Long,et al.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. , 1990, Journal of immunology.

[17]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[18]  L. Hood,et al.  Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies , 1990, The Journal of experimental medicine.

[19]  J. Seidman,et al.  Shared human T cell receptor V beta usage to immunodominant regions of myelin basic protein. , 1990, Science.

[20]  A. Begovich,et al.  Limited heterogeneity of rearranged T-cell receptor Vα transcripts in brains of multiple sclerosis patients , 1990, Nature.

[21]  D. Carlo,et al.  Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. , 1989, Science.

[22]  A. Vandenbark,et al.  Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis , 1989, Nature.

[23]  R. Schwartz.  Acquisition of immunologic self-tolerance , 1989, Cell.

[24]  E. D. Robinson,et al.  Evidence for multiple human T cell recognition sites on myelin basic protein , 1989, Journal of Neuroimmunology.

[25]  D. Bourdette,et al.  Response of human T lymphocyte lines to myelin basic protein: Association of dominant epitopes with HLA class II restriction molecules , 1989, Journal of neuroscience research.

[26]  E. Heber-Katz,et al.  The V-region disease hypothesis: evidence from autoimmune encephalomyelitis. , 1989, Immunology today.

[27]  H. Wekerle,et al.  T cell receptor β chain usage in myelin basic protein‐specific rat T lymphocytes , 1989 .

[28]  N. Shen,et al.  Both rat and mouse T cell receptors specific for the encephalitogenic determinant of myelin basic protein use similar V alpha and V beta chain genes even though the major histocompatibility complex and encephalitogenic determinants being recognized are different , 1989, The Journal of experimental medicine.

[29]  H. Mcdevitt,et al.  Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Gefter,et al.  T cell receptor gene usage in the response to lambda repressor cI protein. An apparent bias in the usage of a V alpha gene element , 1988, The Journal of experimental medicine.

[31]  L. Hood,et al.  Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy , 1988, Cell.

[32]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[33]  H. Mcdevitt,et al.  Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention , 1988, Cell.

[34]  H. Spits,et al.  Complex rearrangements within the human J delta‐C delta/J alpha‐C alpha locus and aberrant recombination between J alpha segments. , 1988, The EMBO journal.

[35]  H. Mcdevitt,et al.  Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis [published erratum appears in J Exp Med 1988 Jul 1;168(1):455] , 1988, The Journal of experimental medicine.

[36]  L. Hood,et al.  Structure, Organization and Polymorphism of Murine and Human T‐Cell Receptor a and β Chain Gene Families , 1988, Immunological reviews.

[37]  P. Morel,et al.  Correlation of T cell receptor V beta gene family with MHC restriction , 1987, The Journal of experimental medicine.

[38]  P. Fink,et al.  Generation of diversity in T cell receptor repertoire specific for pigeon cytochrome c , 1987, The Journal of experimental medicine.

[39]  L. Hood,et al.  Diversity and structure of human T-cell receptor alpha-chain variable region genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Mak,et al.  Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[42]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.

[44]  E. D. Robinson,et al.  Heterogeneity of the T-cell receptor beta gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. , 1991, Annals of neurology.

[45]  V. Barnaba,et al.  New perspectives on immunointervention in autoimmune diseases. , 1990, Immunology today.

[46]  T. Mak,et al.  Sequences and repertoire of the human T cell receptor α and β chain variable region genes in thymocytes , 1987 .